Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
50 studies found for:    Open Studies | "Cytomegalovirus Infections"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Cytomegalovirus Infections" (50 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence
Condition: Cytomegalovirus Infections
Interventions: Drug: Drug conversion to sirolimus;   Drug: Maintenance of the current regimen
2 Recruiting Evaluation of the PK and PD of Ganciclovir in Premature Infants Receiving Treatment for CMV Infection
Condition: Cytomegalovirus Infections
Intervention:
3 Recruiting Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy
Condition: Cytomegalovirus Infections
Intervention: Other: Blood draw and MRI
4 Recruiting A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China
Condition: Congenital Cytomegalovirus Infection
Intervention:
5 Recruiting Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening
Condition: Congenital Cytomegalovirus Infection
Intervention: Other: CMV PCR
6 Not yet recruiting Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis
Conditions: Ulcerative Colitis;   Cytomegalovirus Infections
Intervention:
7 Recruiting Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV
Condition: Congenital Cytomegalovirus Infection
Intervention: Other: olfactory tests, otoacoustic emissions (OAE)
8 Recruiting Cell-mediated Immunity for Prevention of CMV Disease
Condition: Cytomegalovirus Infections
Intervention: Other: T-Track® CMV assay
9 Recruiting Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporineversus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A
Conditions: Transplantation Infection;   Cytomegalovirus Infection
Interventions: Drug: Everolimus;   Drug: mycophenolic acid
10 Recruiting Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV
Condition: Cytomegalovirus Infection
Interventions: Biological: Low dose HB-101;   Biological: Medium dose HB-101;   Biological: High dose HB-101;   Biological: Placebo
11 Recruiting Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers
Condition: Cytomegalovirus Infection
Interventions: Other: Placebo;   Drug: MBX400
12 Recruiting Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT
Condition: Cytomegalovirus Infections
Intervention: Biological: CMV Specific T Cell donor lymphocyte infusion
13 Recruiting Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)
Condition: CMV Infections
Intervention: Biological: Viralym-C
14 Recruiting Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults
Condition: Cytomegalovirus Infections
Interventions: Drug: VBI-1501A;   Drug: VBI-1501;   Drug: Placebo
15 Recruiting Prognostic Value of Neonatal Markers (Clinical, Imaging and Biological) for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus (CMV) in Utero
Condition: Congenital Cytomegalovirus Infection
Intervention: Other: Standardized test report
16 Recruiting Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation
Conditions: Cytomegalovirus Infection;   Adenovirus Infection
Intervention: Biological: virus-specific T-Cells
17 Recruiting The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population
Condition: Renal Transplant Recipients
Interventions: Drug: Valganciclovir;   Drug: Ganciclovir
18 Recruiting Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: CMV Infection;   Persistent CMV Viremia
Intervention: Genetic: CMVpp65 Specific T-cells
19 Not yet recruiting Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection
Condition: Cytomegalovirus Infections
Intervention: Biological: IFN-γ positive selected T-cells
20 Recruiting MSC for Treatment of CMV Infection
Conditions: Stem Cell Transplantation, Hematopoietic;   CMV Infection;   Hematological Diseases
Intervention: Biological: MSCs

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.